NCT02642003View on ClinicalTrials.gov

To Assess the Efficacy of Granulocyte Colony Stimulating Factor Versus Standard Medical Therapy in Patients of Decompensated Cirrhosis

PHASE3CompletedINTERVENTIONAL

Enrollment

259

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

January 31, 2016

Study Completion Date

February 29, 2016

Conditions

Cirrhosis

Interventions

DRUG

Granulocyte Colony Stimulating Factor

Trial Locations (1)

110060

Department of Gastroenterology & Hepatology, Sir Ganga Ram Hospital, New Delhi

All Listed Sponsors

lead

Sir Ganga Ram Hospital

OTHER

NCT02642003 - To Assess the Efficacy of Granulocyte Colony Stimulating Factor Versus Standard Medical Therapy in Patients of Decompensated Cirrhosis | Biotech Hunter | Biotech Hunter